People · Operator
Named in public records as an officer, director or promoter · active 2005–2018 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Sound Pharmaceuticals Inc | — | Biotechnology | Series A | $21.6M | $304.0M | 2005 |
Jonathan Kil at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jonathan Kil on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Guyer | 1 | 8 |
| James C. Towne | 1 | 4 |
| Paul Thompson | 1 | 3 |
| Joseph Ashley | 1 | 3 |
| James Paul Rickey | 1 | 3 |
| John C. Sullivan | 1 | 2 |
| Glenn Kawasaki | 1 | 2 |
| Eric Lynch | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.